See analyst estimates and all valuation multiples for Nutraceuticals & Cosmeceuticals
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $28.9B | 1.8x | 7.6x | |
| $17.7B | 15.7x | 48.9x | |
| $17.1B | 11.1x | 33.4x | |
| $10.9B | 3.4x | 8.3x | |
| $7.1B | 9.4x | 34.8x | |
| $7.1B | 4.6x | 23.4x | |
| $4.5B | 12.6x | 29.7x | |
| $3.8B | 1.7x | 10.3x | |
| $3.2B | n/a | n/a | |
| $3.1B | 1.5x | 9.8x | |
| $3.0B | 2.2x | 8.0x | |
| $2.2B | 7.1x | 13.6x | |
| $1.7B | n/a | n/a | |
| $1.4B | 2.4x | 12.5x | |
| $1.3B | 5.9x | 22.6x | |
| $1.2B | 8.2x | 28.1x | |
| $1.1B | 1.0x | 4.1x | |
| $1.0B | 6.6x | 21.0x | |
| $996M | n/a | n/a | |
| $994M | n/a | n/a | |
| $983M | n/a | n/a | |
| $939M | 3.8x | 9.8x | |
| $787M | 1.8x | 8.5x | |
| $709M | 6.0x | 49.8x | |
| $663M | 15.6x | 44.6x | |
| $516M | n/a | n/a | |
| $467M | 3.1x | 12.1x | |
| $203M | 3.1x | n/a | |
| $175M | 2.2x | 12.3x | |
| $128M | 2.7x | 11.2x | |
| $94.6M | n/a | n/a | |
| $49.6M | 1.2x | 4.5x | |
| $28.4M | n/a | n/a | |
| $20.5M | n/a | n/a | |
| $20.3M | 0.8x | -50.3x | |
| $15.9M | 10.5x | -1.5x | |
| $8.3M | n/a | n/a | |
| $5.6M | n/a | n/a | |
| $3.9M | n/a | n/a | |
| -$3.1M | n/a | n/a | |
| -$3.2M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Nutraceuticals & Cosmeceuticals